Tema Heart & Health ETF (NASDAQ:HRTS) Trading Down 1.1% – Should You Sell?

Shares of Tema Heart & Health ETF (NASDAQ:HRTS) traded down 1.1% during mid-day trading on Thursday . The stock traded as low as $33.50 and last traded at $33.53. 1,795 shares changed hands during trading, a decline of 73% from the average session volume of 6,699 shares. The stock had previously closed at $33.89.

Tema Heart & Health ETF Trading Down 1.1%

The stock has a market capitalization of $49.96 million, a P/E ratio of 22.06 and a beta of 0.70. The firm’s fifty day moving average is $33.97 and its 200-day moving average is $34.62.

Hedge Funds Weigh In On Tema Heart & Health ETF

Institutional investors have recently added to or reduced their stakes in the company. Kestra Advisory Services LLC bought a new position in Tema Heart & Health ETF during the 4th quarter valued at about $27,000. JPMorgan Chase & Co. bought a new position in Tema Heart & Health ETF during the 2nd quarter valued at about $63,000. Citadel Advisors LLC bought a new position in Tema Heart & Health ETF during the 3rd quarter valued at about $243,000. Brookstone Capital Management bought a new position in Tema Heart & Health ETF during the 4th quarter valued at about $364,000. Finally, Stifel Financial Corp lifted its holdings in Tema Heart & Health ETF by 19.8% during the 4th quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock valued at $1,187,000 after purchasing an additional 5,571 shares during the last quarter.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.